Apigenin 7-O-glucoside is amongst very important secondary metabolites, which is produced by
Cosmos bipinnatus.
Cosmos bipinnatus has been used in phytomedicine for numerous diseases, such as jaundice, spasmodic fever, and anti-inflammatory activity (
1). Jang et al. (2008) reported antioxidative and antigenotoxic activity for
C. bipinnatus extracts (
2). They suggested that it has important antioxidant activity and protecting effect against oxidative DNA damage. Olajuyigbe and Ashafa (2014) reported the chemical composition of essential oils of
C. bipinnatus and its antibacterial activity (
3). Zheng et al. (2005) suggested that the hepatoprotective activity of apigenin is due to its antioxidant properties, performing as an ROS scavengers (
4). Sohn et al. (2013) reported that a sesquiterpene lactone isolated from the roots of
C. bipinnatus demonstrates an anti-inflammatory effect (
1). It exhibits anti-inflammatory, anti-mutagenic, antiviral, and purgative effects (
5,
6).
Pharmaceutical secondary metabolites have been used for the cure of numerous illnesses and are becoming a significant research area for drug discovery (
7-
11). Choi et al. (2009) reported that it may be a very useful anticancer drug candidate for chemotherapy and cancer prevention (
12). Way et al. (2004) revealed anti-proliferative properties of apigenin on some cell lines of human breast cancer (
13). It strongly inhibited tumor cell invasion in a breast tumor cell line (
14). Zheng et al. (2005) reported that apigenin inhibited the growth of HeLa cells by inducing apoptosis (
15). Wang et al. (2000) reported that the use of apigenin in colon carcinoma cell lines caused G
2/M cell cycle arrest and cell growth inhibition (
16). Wang et al. (1999) reported that apigenin is very effective in inducing apoptosis on human leukemia cells (
17). In another study, Budhraja et al. (2011) reported that Akt signaling pathways are possible objectives for inducing apoptosis in leukemia cells, using apigenin (
18). Li et al. (2007) reported that it could inhibit lung cancer cell proliferation (
19). Gupta et al. (2001) assessed the growth inhibitory properties of apigenin on human prostate cancer (
20). Shukla and Gupta (2010) demonstrated that apigenin could support the improvement of cardiovascular disorders, excite immune system and deliver some defense alongside skin, thyroid, endometrial, gastric, liver, and adrenal cortical cancers (
21). Patel et al. (2007) suggested that in the future, apigenin owns high possibility for progress as a capable cancer chemopreventive factor (
22).
Root-based culture technology has become a sustainable production platform for producing specific pharmaceutical secondary metabolites.
Agrobacterium rhizogenes are gram negative bacteria, which induce hairy roots in plants. The T-DNA from its Ri plasmid can be transferred to the plant genome. T-DNA encodes the enzymes for phytohormone auxin control and biosynthesis of cytokinin. Root-inducing (Ri) plasmid contains
rol (root loci) genes harbored by
A. rhisogenes. The
rol genes are integrated into the genome of the host plant, producing a hairy root. The
rol genes are believed to influence transformed roots growth and development, and prompt synthesis of secondary metabolite via turning on the transcription defense genes. The
rolB gene is very crucial for genetically transformed root production (
23). Genetically transformed roots are mostly used as a transgenic tool for secondary metabolites production and evaluation of key genes in secondary metabolite pathway studies. Hairy roots are both genetically and biochemically stable over long culture periods in comparison to cell suspension cultures. The biosynthesis of secondary metabolites is induced by increasing plant defense genes expression. Fast growth of hairy roots offers an additional benefit to use as a continuous source for valuable secondary metabolite production in the absence of growth regulators (which are usually expensive) in a sterile culture medium (
24-
26). For increasing the production of pharmaceutical compounds in hairy root cultures, the identification of key genes, which are involved in regulating secondary metabolic pathway stages can aid in secondary metabolic engineering. Fortunately, over the past decades, much information about the biochemistry and genetics of biosynthetic pathways involved in plant natural products creation has been illustrated (
27,
28). Gene-coding committed enzymes and strategic transcription factors should be used for increasing preferred secondary metabolites production by overexpressing them in genetically transformed root cultures (
25,
29). Genetically transformed root culture as a green factory has biotechnological potential for producing high-value plant-derived metabolites and recombinant pharmaceutical proteins (
30).
Numerous features effect the frequency of
A. rhizogenes mediated transformation. Sharafi et al. (2014a) used liquid inoculation and solid co-cultivation media in absence of macro elements, such as KH
2PO
4, NH
4NO
3, KNO
3 and CaCl
2, to transform medicinal plant
Dracocephalum kotschyi with high efficiency (
31). In another study, Henzi et al. (2000) indicated that the usage of acetosyringone and arginine in the agar solidified co-cultivation medium, which revealed major enhancement in transformation rate of
Brassica by
Agrobacterium (
32).